Fresenius Medical Care AG & Co. KGaA (ETR:FME) Given a €82.00 Price Target by Nord/LB Analysts

Nord/LB set a €82.00 ($95.35) price objective on Fresenius Medical Care AG & Co. KGaA (ETR:FME) in a research note released on Thursday morning, Borsen Zeitung reports. The brokerage currently has a buy rating on the stock.

Other analysts have also issued research reports about the stock. HSBC set a €93.00 ($108.14) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a buy rating in a report on Thursday, April 25th. Berenberg Bank set a €89.95 ($104.59) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a buy rating in a report on Friday, July 26th. Deutsche Bank set a €100.00 ($116.28) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a buy rating in a report on Wednesday. Credit Suisse Group set a €71.00 ($82.56) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a neutral rating in a report on Thursday. Finally, Independent Research set a €74.00 ($86.05) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a neutral rating in a report on Monday, June 17th. Seven analysts have rated the stock with a hold rating and ten have given a buy rating to the stock. The stock has an average rating of Buy and an average price target of €81.19 ($94.41).

Shares of FME traded down €1.10 ($1.28) during mid-day trading on Thursday, hitting €61.72 ($71.77). The company’s stock had a trading volume of 1,150,009 shares, compared to its average volume of 704,197. The company has a debt-to-equity ratio of 104.77, a current ratio of 0.99 and a quick ratio of 0.13. The stock has a market capitalization of $18.84 billion and a price-to-earnings ratio of 15.34. The business has a 50-day moving average of €68.51. Fresenius Medical Care AG & Co. KGaA has a 1-year low of €55.44 ($64.47) and a 1-year high of €91.74 ($106.67).

About Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services in Germany, the United States, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.

Featured Story: Gap Up Stocks

Analyst Recommendations for Fresenius Medical Care AG & Co. KGaA (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.